(UBU7) UBS (Irl) - MSCI World - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B7KQ7B66
UBU7: Global, Large-Cap, Equities, Blend
The UBS (Irl) ETF plc - MSCI World UCITS ETF (USD) A-dis EUR is an exchange-traded fund that tracks the Morningstar Global TME NR USD index, providing investors with broad exposure to the global equity market. As a Global Large-Cap Blend Equity ETF, it invests in a diverse portfolio of large-cap stocks from around the world, aiming to replicate the performance of the underlying index.
With its domicile in Germany and listing on XETRA, the ETF offers a convenient investment vehicle for European investors seeking to gain exposure to the global equity market. The fund is managed by UBS, a reputable asset management firm with a strong track record in ETF management.
Analyzing the ETFs technical data, we observe that the current price is 82.82 EUR, with a 20-day simple moving average (SMA) of 79.10 EUR, indicating a recent upward trend. The 50-day SMA is 82.55 EUR, closely aligned with the current price, while the 200-day SMA is 85.42 EUR, suggesting a potential resistance level. The average true range (ATR) is 2.02 EUR, or 2.43% of the current price, indicating moderate volatility.
From a fundamental perspective, the ETF has assets under management (AUM) of 318.76 million EUR, indicating a relatively modest size compared to other ETFs in the Global Large-Cap Blend Equity category. However, this size can be beneficial for investors as it allows for more agile management and potentially lower trading costs.
Forecasting the ETFs future performance, we can analyze the technical and fundamental data. Given the recent upward trend and the ETFs proximity to its 52-week high of 93.59 EUR, we can expect the price to continue to move upwards, potentially testing the 200-day SMA as resistance. However, the ATR indicates moderate volatility, and any significant news or market events could impact the price. Based on the SMA20 and SMA50, a bullish crossover is evident, suggesting a potential buy signal. Therefore, we forecast a potential price target of 90 EUR in the short term, with a stop-loss around 78 EUR to limit potential losses.
Additional Sources for UBU7 ETF
UBU7 ETF Overview
Market Cap in USD | 372m |
Category | Global Large-Cap Blend Equity |
TER | 0.10% |
IPO / Inception | 2012-04-11 |
UBU7 ETF Ratings
Growth Rating | 67.9 |
Fundamental | - |
Dividend Rating | 58.1 |
Rel. Strength | -8.96 |
Analysts | - |
Fair Price Momentum | 97.95 EUR |
Fair Price DCF | - |
UBU7 Dividends
Dividend Yield 12m | 1.49% |
Yield on Cost 5y | 2.82% |
Annual Growth 5y | 8.21% |
Payout Consistency | 95.1% |
Payout Ratio | % |
UBU7 Growth Ratios
Growth Correlation 3m | 64.3% |
Growth Correlation 12m | 31.7% |
Growth Correlation 5y | 89.9% |
CAGR 5y | 13.43% |
CAGR/Max DD 5y | 0.62 |
Sharpe Ratio 12m | 0.70 |
Alpha | -5.99 |
Beta | 0.757 |
Volatility | 10.09% |
Current Volume | 1.2k |
Average Volume 20d | 2.9k |
As of June 27, 2025, the stock is trading at EUR 85.63 with a total of 1,182 shares traded.
Over the past week, the price has changed by +0.71%, over one month by -0.09%, over three months by -0.84% and over the past year by +5.03%.
Yes. Based on ValueRay´s Analyses, UBS (Irl) - MSCI World (XETRA:UBU7) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.88 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UBU7 is around 97.95 EUR . This means that UBU7 is currently undervalued and has a potential upside of +14.39% (Margin of Safety).
UBS (Irl) - MSCI World has no consensus analysts rating.
According to our own proprietary Forecast Model, UBU7 UBS (Irl) - MSCI World will be worth about 111.8 in June 2026. The stock is currently trading at 85.63. This means that the stock has a potential upside of +30.5%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 111.8 | 30.5% |